Genmab A (GMAB) Total Current Liabilities: 2018-2020

Historic Total Current Liabilities for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $146.0 million.

  • Genmab A's Total Current Liabilities fell 22.66% to $160.42 in Q2 2021 from the same period last year, while for Jun 2021 it was $160.42, marking a year-over-year decrease of 22.66%. This contributed to the annual value of $146.0 million for FY2020, which is 49.86% up from last year.
  • Latest data reveals that Genmab A reported Total Current Liabilities of $146.0 million as of FY2020, which was up 49.86% from $97.4 million recorded in FY2019.
  • Over the past 5 years, Genmab A's Total Current Liabilities peaked at $146.0 million during FY2020, and registered a low of $49.0 million during FY2018.
  • Over the past 3 years, Genmab A's median Total Current Liabilities value was $97.4 million (recorded in 2019), while the average stood at $97.5 million.
  • Data for Genmab A's Total Current Liabilities shows a peak YoY surged of 98.79% (in 2019) over the last 5 years.
  • Genmab A's Total Current Liabilities (Yearly) stood at $49.0 million in 2018, then soared by 98.79% to $97.4 million in 2019, then soared by 49.86% to $146.0 million in 2020.